Atlas Trials

Advanced Ovarian Cancer

28 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Ovarian Cancer

RecordFirmDate
SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS (NCT04862325)Hospital Clinic of Barcelona2021-04-20
Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer (NCT04556539)Jiangxi Qingfeng Pharmaceutical Co. Ltd.2020-12-15
The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer (NCT04065009)Karolinska Institutet2020-08-26
Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer (NCT04360629)Jun Zhang2020-06-03
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer (NCT04135521)Far Eastern Memorial Hospital2019-10-28
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer (NCT03878849)Allarity Therapeutics2019-04-15
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients (NCT03737643)AstraZeneca2019-01-04
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer (NCT03611179)Nada Hassan Salah2018-09-01
Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin (NCT03161132)Grupo Español de Investigación en Cáncer de Ovario2017-12-13
A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer (NCT03292172)Hoffmann-La Roche2017-11-08
The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial (NCT03158935)University Health Network, Toronto2017-07-07
Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations (NCT01989546)National Cancer Institute (NCI)2014-02-04
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. (NCT01844986)AstraZeneca2013-08-26
Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer (NCT01462149)Asan Medical Center2011-10-01
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel (NCT00516724)AstraZeneca2007-06-22

Track Advanced Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.